Literature DB >> 8352686

The content and cost of cataract surgery.

E P Steinberg1, J C Javitt, P D Sharkey, A Zuckerman, M W Legro, G F Anderson, E B Bass, D O'Day.   

Abstract

Although more than 1 million cataract surgeries are performed annually in the United States, little is known about the frequency of use or cost of various services provided in connection with this procedure. To assess the frequency with which various ophthalmic, optometric, anesthesia, and medical services are provided in conjunction with cataract surgery and to estimate the cost to Medicare associated with those services, we analyzed 1985 through 1988 Medicare claims records of a nationally representative 5% sample of Medicare beneficiaries. The experience of 57,103 Medicare beneficiaries who underwent extracapsular cataract surgery in 1986 or 1987 that was not combined with another ophthalmologic procedure formed the basis of our analysis. Projections for current costs were performed using 1991 charges allowed by Medicare for physician services. We estimate that the median charge allowed by Medicare for a "typical" episode of cataract surgery in 1991 was approximately $2500. In addition to the $3.4 billion that Medicare spent in 1991 on such "typical" episodes, Medicare spent more than $39 million on miscellaneous "atypical" preoperative ophthalmologic tests, such as specular microscopy (14% of cases) and potential acuity testing (8% of cases), more than $7 million on postoperative ophthalmologic diagnostic tests, such as fluorescein angiography (3% of cases), and more than $18 million on perioperative medical services (most commonly electrocardiography and chest roentgenography). The major determinants of the cost to Medicare associated with cataract surgery are the rate of performance of cataract surgery and neodymium-YAG laser capsulotomy and the charges allowed for these procedures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8352686     DOI: 10.1001/archopht.1993.01090080037016

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  31 in total

Review 1.  Role of cytokines in the pathogenesis of posterior capsule opacification.

Authors:  W R Meacock; D J Spalton; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Intraocular lens implants. Have come a long way, but the advances are not yet available to all.

Authors:  B Allan
Journal:  BMJ       Date:  2000-01-08

Review 3.  Management of cataract.

Authors:  R Dickson; A Eastwood; P Gill; A Melville; S O'Meara; T Sheldon
Journal:  Qual Health Care       Date:  1996-09

4.  Preoperative medical testing in Medicare patients undergoing cataract surgery.

Authors:  Catherine L Chen; Grace A Lin; Naomi S Bardach; Theodore H Clay; W John Boscardin; Adrian W Gelb; Mervyn Maze; Michael A Gropper; R Adams Dudley
Journal:  N Engl J Med       Date:  2015-04-16       Impact factor: 91.245

5.  Nd:YAG capsulotomy rates after use of the AcrySof acrylic three piece and one piece intraocular lenses.

Authors:  S I Mian; K Fahim; A Marcovitch; H Gada; D C Musch; A Sugar
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

6.  Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study.

Authors:  E-M Chia; P Mitchell; E Rochtchina; S Foran; J J Wang
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 7.  The surgical management of cataract: barriers, best practices and outcomes.

Authors:  Margaret A Chang; Nathan G Congdon; Shawn K Baker; Martin W Bloem; Howard Savage; Alfred Sommer
Journal:  Int Ophthalmol       Date:  2007-08-22       Impact factor: 2.031

8.  Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes.

Authors:  Tianlin Xiao; Mohammad Shoeb; M Saeed Siddiqui; Min Zhang; Kota V Ramana; Satish K Srivastava; Vasilis Vasiliou; Naseem H Ansari
Journal:  J Toxicol Environ Health A       Date:  2009

9.  Do patients with age related maculopathy and cataract benefit from cataract surgery?

Authors:  G N Shuttleworth; E A Luhishi; R A Harrad
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

10.  Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.

Authors:  Heather L Chandler; Curtis A Barden; Ping Lu; Donna F Kusewitt; Carmen M H Colitz
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.